ValuationViz

ADPT fund manager activity

Adaptive Biotechnologies Corporation · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.

Q4 2024

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsNo change29,993,708$179,812,2790.58%Feb 14, 2025

Q3 2024

ManagerActivitySharesValue% of portfolioFiled
Viking Global InvestorsNo change29,993,708$153,567,7850.56%Nov 14, 2024

Newer quarters · Older quarters